Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Parasitic Diseases

Free Subscription Articles published in Exp Parasitol Retrieve available abstracts of 65 articles: HTML format

Single Articles

May 2023
1. FREITAS CS, Santiago SS, Lage DP, Antinarelli LMR, et al
   In vitro evaluation of antileishmanial activity, mode of action and cellular response induced by vanillin synthetic derivatives against Leishmania species able to cause cutaneous and visceral leishmaniasis.
   Exp Parasitol. 2023;251:108555.
   PubMed     Abstract available
   
   
   
2. GONCALVES-OLIVEIRA LF, Peixoto JF, Dias-Lopes G, Souza da Silva F, et al
   Assessing nystatin cream treatment efficacy against Leishmania (L.) amazonensis infection in BALB/c model.
   Exp Parasitol. 2023 May 15:108547. doi: 10.1016/j.exppara.2023.108547.
   PubMed     Abstract available
   
   
   March 2023
3. TEH-POOT CF, Dzul-Huchim VM, Mercado JM, Villanueva-Lizama LE, et al
   A short-term method to evaluate anti-leishmania drugs by inhibition of stage differentiation in Leishmania mexicana using flow cytometry.
   Exp Parasitol. 2023 Mar 31:108519. doi: 10.1016/j.exppara.2023.108519.
   PubMed     Abstract available
   
   
   
4. MANSOUR SM, Ibrahim AM
   Differentiation between Bulinus truncatus and Bulinus hexaploidus by morphological characters, chromosomal study and compatibility with Schistosoma haematobium.
   Exp Parasitol. 2023 Mar 11:108502. doi: 10.1016/j.exppara.2023.108502.
   PubMed     Abstract available
   
   
   
5. ZHONG H, Qin F, Ren Y, Li X, et al
   Functional characterization of differentially expressed proteins coming from unisexual and bisexual infected Schistosoma japonicum female worms.
   Exp Parasitol. 2023 Mar 11:108504. doi: 10.1016/j.exppara.2023.108504.
   PubMed     Abstract available
   
   
   February 2023
6. PAULINO S, Santos L, Rabello M, da Silva P, et al
   Development of solid dispersions based on 3- (2,6-difluorobenzyl) -5- (5-bromo-1H-indol-3-ylmethylene) thiazolidine-2,4-dione for schistosomicidal treatment.
   Exp Parasitol. 2023 Feb 8:108455. doi: 10.1016/j.exppara.2022.108455.
   PubMed     Abstract available
   
   
   January 2023
7. SHARMA A, Chauhan BS, Yadav K, Chaudhary NR, et al
   Molecular and immunological characterization of the calcyclin binding protein in rodent malaria parasite.
   Exp Parasitol. 2023 Jan 24:108475. doi: 10.1016/j.exppara.2023.108475.
   PubMed     Abstract available
   
   
   
8. FERREIRA BA, Coser EM, Saborito C, Yamashiro-Kanashiro EH, et al
   In vitro miltefosine and amphotericin B susceptibility of strains and clinical isolates of Leishmania species endemic in Brazil that cause tegumentary leishmaniasis.
   Exp Parasitol. 2023;246:108462.
   PubMed     Abstract available
   
   
   December 2022
9. RAHMANIPOUR M, Mohebali M, Koosha M, Kazemirad E, et al
   Effect of Leishmania RNA virus 2 on virulence factors and cytokines gene expression in a human macrophage infected with Leishmania major: A preliminary study.
   Exp Parasitol. 2022 Dec 31:108459. doi: 10.1016/j.exppara.2022.108459.
   PubMed     Abstract available
   
   
   
10. DARIF D, Nait Irahal I, Hammi I, Kihel A, et al
    Capparis spinosa inhibits Leishmania major growth through nitric oxide production in vitro and arginase inhibition in silico.
    Exp Parasitol. 2022 Dec 26:108452. doi: 10.1016/j.exppara.2022.108452.
    PubMed     Abstract available
    
    
    
11. MAHOR H, Mukherjee A, Sarkar A, Saha B, et al
    Anti-leishmanial therapy: Caught between drugs and immune targets.
    Exp Parasitol. 2022 Dec 23:108441. doi: 10.1016/j.exppara.2022.108441.
    PubMed     Abstract available
    
    
    
12. FOTOOHI S, Radfar MH, Afgar A, Harandi MF, et al
    Anti-echinococcal effects of sumac, Rhus coriaria, in a murine model of cystic echinococcosis: Parasitological and molecular evaluation.
    Exp Parasitol. 2022;243:108406.
    PubMed     Abstract available
    
    
    November 2022
13. YOUSEFI S, Paksa A, Gorouhi MA, Alizadeh I, et al
    Determination of the feeding behavior of Phlebotomus sergenti using multiplex PCR and tent-baited traps in a new focus of Anthroponotic Cutaneous Leishmaniasis in the southeast of Iran.
    Exp Parasitol. 2022 Nov 15:108426. doi: 10.1016/j.exppara.2022.108426.
    PubMed     Abstract available
    
    
    
14. CHIAMAH OC, Ubachukwu PO, Okafor FC, Shoyinka SVO, et al
    Low doses and short duration of prednisolone administration in guinea pigs experimentally infected with Schistosoma haematobium: Histopathology of liver and lungs.
    Exp Parasitol. 2022;244:108425.
    PubMed     Abstract available
    
    
    
15. PERALES MACEDO DMB, Diaz Pernett SC, Diaz Gonzalez MG, Torres Nieves GM, et al
    Autochthonous transmission of the Indomalayan parasite, Transversotrema patialense, in the Caribbean: Molecular, morphological, and experimental evidence.
    Exp Parasitol. 2022;242:108368.
    PubMed     Abstract available
    
    
    October 2022
16. OLIVEIRA IHR, Kjeldsen F, Melo-Braga MN, Verano-Braga T, et al
    Assessing the effects of Leishmania (Leishmania) infantum and L. (L.) amazonensis infections in macrophages using a quantitative proteome approach.
    Exp Parasitol. 2022;243:108413.
    PubMed     Abstract available
    
    
    
17. SHEKHAR S, Bhowmick K, Dhar SK
    Role of PfMYST in DNA replication in Plasmodium falciparum.
    Exp Parasitol. 2022 Oct 10:108396. doi: 10.1016/j.exppara.2022.108396.
    PubMed     Abstract available
    
    
    
18. GOMES ECS, Barbosa Junior WL, Melo FL
    Evaluation of SmITS1-LAMP performance to diagnosis schistosomiasis in human stool samples from an endemic area in Brazil.
    Exp Parasitol. 2022 Oct 4:108389. doi: 10.1016/j.exppara.2022.108389.
    PubMed     Abstract available
    
    
    
19. GANJI A, Jalali-Mashayekhi F, Hajihossein R, Eslamirad Z, et al
    Anti-parasitic effects of resveratrol on protoscolices and hydatid cyst layers.
    Exp Parasitol. 2022;241:108360.
    PubMed     Abstract available
    
    
    September 2022
20. SALAH F, Maher K, Demerdash Z, El Baz H, et al
    Lab-scale production of anti-Schistosoma monoclonal antibodies by hybridoma culturing in serum free medium: Enhancement of growth, cryopreservation survival rate, and diagnostic accuracy.
    Exp Parasitol. 2022 Sep 27:108390. doi: 10.1016/j.exppara.2022.108390.
    PubMed     Abstract available
    
    
    
21. GIRALDO M, Upegui YA, Higuita-Castro JL, Gonzalez LA, et al
    Effect of the variation in the extracellular concentration of l-arginine in the physiology of Leishmania (Viannia) braziliensis and its susceptibility to some antileishmanial drugs.
    Exp Parasitol. 2022 Sep 27:108395. doi: 10.1016/j.exppara.2022.108395.
    PubMed     Abstract available
    
    
    
22. BRANDAO-BEZERRA L, Aparecida da Rosa A, Figueiredo de Oliveira RM, Neves RH, et al
    Impact of acute schistosomiasis mansoni and long-term ethanol intake on mouse liver pathology.
    Exp Parasitol. 2022 Sep 26:108388. doi: 10.1016/j.exppara.2022.108388.
    PubMed     Abstract available
    
    
    
23. KUAPRASERT B, Chitnumsub P, Leartsakulpanich U, Suginta W, et al
    Dual role of azo compounds in inhibiting Plasmodium falciparum adenosine deaminase and hemozoin biocrystallization.
    Exp Parasitol. 2022 Sep 22:108384. doi: 10.1016/j.exppara.2022.108384.
    PubMed     Abstract available
    
    
    
24. CUNHA ARAUJO IA, Cristina de Paula R, Alves CL, Faria KF, et al
    In vitro efficacy of isoflavonoids and terpenes against Leishmania (Leishmania) infantum and L. amazonensis.
    Exp Parasitol. 2022 Sep 21:108383. doi: 10.1016/j.exppara.2022.108383.
    PubMed     Abstract available
    
    
    
25. STARKLOFF NC, Hartman RB, Civitello DJ
    Snail juvenile growth rate as a rapid predictor of the transmission potential of parasitizing human schistosomes.
    Exp Parasitol. 2022 Sep 9:108378. doi: 10.1016/j.exppara.2022.108378.
    PubMed     Abstract available
    
    
    August 2022
26. MUKHERJEE N, Banerjee S, Amin SA, Jha T, et al
    Host P2X7R-p38MAPK axis mediated intra-macrophage leishmanicidal activity of Spergulin-A.
    Exp Parasitol. 2022 Aug 22:108365. doi: 10.1016/j.exppara.2022.108365.
    PubMed     Abstract available
    
    
    
27. LIMA TC, Magalhaes LG, de L Paula LA, Cunha WR, et al
    In vivo schistosomicidal activity of (+/-)-licarin A-loaded poly(epsilon-caprolactone) nanoparticles.
    Exp Parasitol. 2022 Aug 20:108357. doi: 10.1016/j.exppara.2022.108357.
    PubMed     Abstract available
    
    
    
28. ALVES AF, Pereira RA, Rodrigues MA, Campos LS, et al
    Leishmania (L.) infantum BH401 strain induces classic renal lesions in dogs: Histological and confocal microscopy study.
    Exp Parasitol. 2022 Aug 17:108342. doi: 10.1016/j.exppara.2022.108342.
    PubMed     Abstract available
    
    
    
29. SABERI R, Fakhar M, Hajjaran H, Abbaszadeh Afshar MJ, et al
    Leishmania RNA virus 2 (LRV2) exacerbates dermal lesions caused by Leishmania major and comparatively unresponsive to meglumine antimoniate treatment.
    Exp Parasitol. 2022 Aug 3:108340. doi: 10.1016/j.exppara.2022.108340.
    PubMed     Abstract available
    
    
    July 2022
30. DE MORAIS RCS, de Melo MGN, de Goes TC, Pessoa E Silva R, et al
    Clinical-therapeutic follow-up of patients with American cutaneous leishmaniasis caused by different Leishmania spp. in Brazil.
    Exp Parasitol. 2022 Jul 30:108338. doi: 10.1016/j.exppara.2022.108338.
    PubMed     Abstract available
    
    
    
31. DOS REIS LFC, Cerdeira CD, Gagliano GS, de Figueiredo ABT, et al
    Alternate-day fasting, a high-sucrose/caloric diet and praziquantel treatment influence biochemical and behavioral parameters during Schistosoma mansoni infection in male BALB/c mice.
    Exp Parasitol. 2022;240:108316.
    PubMed     Abstract available
    
    
    
32. OLIVEIRA FMS, Kraemer L, Cavalcanti da Silva C, Nogueira DS, et al
    Nitric oxide contributes to liver inflammation and parasitic burden control in Ascaris suum infection.
    Exp Parasitol. 2022;238:108267.
    PubMed     Abstract available
    
    
    
33. CAVALLONE IN, de Lima SKS, Oliveira KS, Passero LFD, et al
    Histological and neuronal changes in the duodenum of hamsters infected with Leishmania (Leishmania) infantum.
    Exp Parasitol. 2022;239:108315.
    PubMed     Abstract available
    
    
    June 2022
34. ELMALAWANY AM, Osman GY, Elashwal MS, Mohamed AH, et al
    Protective role of Balanities aegyptiaca fruit aqueous extract in mice infected with Schistosoma mansoni.
    Exp Parasitol. 2022;239:108290.
    PubMed     Abstract available
    
    
    
35. SAAD AE, Ashour DS, Osman EM
    Different panel of toll-like receptors expression during chronic Schistosoma mansoni infection in experimental animals.
    Exp Parasitol. 2022;239:108317.
    PubMed     Abstract available
    
    
    
36. KUANG Z, Zhang C, Meng Y, Yi F, et al
    Matrix-assisted laser desorption ionization time-of-flight mass spectrometry: An effective method for identification and phylogenetic analysis of Leishmania species.
    Exp Parasitol. 2022 Jun 25:108278. doi: 10.1016/j.exppara.2022.108278.
    PubMed     Abstract available
    
    
    
37. MIURA M, Mitsui Y, Aoki Y, Kato K, et al
    A new accumulation assay of Schistosoma mansoni miracidia using square capillary glass tubes.
    Exp Parasitol. 2022;239:108313.
    PubMed     Abstract available
    
    
    
38. REN Y, Li M, Shi Y, Liu P, et al
    Schistosoma japonicum proteins that interact with the gynecophoral canal protein identified using a yeast two-hybrid system.
    Exp Parasitol. 2022;239:108305.
    PubMed     Abstract available
    
    
    
39. VAKILI B, Nezafat N, Negahdaripour M, Ghasemi Y, et al
    A structural vaccinology approach for in silico designing of a potential self-assembled nanovaccine against Leishmania infantum.
    Exp Parasitol. 2022;239:108295.
    PubMed     Abstract available
    
    
    
40. ALVES ML, Silva DTD, Spada JCP, Leonel JAF, et al
    Use of the intradermal leishmanin test (Montenegro skin test) for feline visceral leishmaniosis: Detection of cellular immunity.
    Exp Parasitol. 2022 Jun 6:108294. doi: 10.1016/j.exppara.2022.108294.
    PubMed     Abstract available
    
    
    
41. SABRA AA, Salem MB, William S, Hammam OA, et al
    Itraconazole, a cytochrome P450 inhibitor, enhanced the efficacy of praziquantel against Schistosoma mansoni infection and alleviated liver injury in mice.
    Exp Parasitol. 2022 Jun 3:108293. doi: 10.1016/j.exppara.2022.108293.
    PubMed     Abstract available
    
    
    
42. GHOSH R, Jawed JJ, Roy N, Mandal S, et al
    Regulatory role of Transcription factor-EB (TFEB) in parasite control through alteration of antigen presentation in visceral leishmaniasis.
    Exp Parasitol. 2022 Jun 2:108286. doi: 10.1016/j.exppara.2022.108286.
    PubMed     Abstract available
    
    
    
43. ELZOHEIRY MA, Elmehankar MS, Aboukamar WA, El-Gamal R, et al
    Fluconazole as Schistosoma mansoni cytochrome P450 inhibitor: In vivo murine experimental study.
    Exp Parasitol. 2022 Jun 2:108291. doi: 10.1016/j.exppara.2022.108291.
    PubMed     Abstract available
    
    
    May 2022
44. RAHMAN MM, McFadden G, Ruthel G, Herbert DR, et al
    Oncolytic Myxoma virus infects and damages the tegument of the human parasitic flatworm Schistosoma mansoni.
    Exp Parasitol. 2022 May 19:108263. doi: 10.1016/j.exppara.2022.108263.
    PubMed     Abstract available
    
    
    
45. TEIXEIRA RR, Rodrigues Gazolla PA, Borsodi MPG, Castro Ferreira MM, et al
    Eugenol derivatives with 1,2,3-triazole moieties: Oral treatment of cutaneous leishmaniasis and a quantitative structure-activity relationship model for their leishmanicidal activity.
    Exp Parasitol. 2022 May 5:108269. doi: 10.1016/j.exppara.2022.108269.
    PubMed     Abstract available
    
    
    
46. YE Z, Ni W, Zhang J, Zhang Y, et al
    Molecular characterization of a profilin gene from a parasitic ciliate Cryptocaryon irritans.
    Exp Parasitol. 2022;236-237:108248.
    PubMed     Abstract available
    
    
    
47. SOARES LA, Matias IC, Silva SS, Ramos MEO, et al
    Parasitological, serological and molecular diagnosis of Dirofilaria immitis in dogs in Northeastern Brazil.
    Exp Parasitol. 2022;236-237:108233.
    PubMed     Abstract available
    
    
    April 2022
48. FAHMY AM, William S, Hegab A, Tm D, et al
    Schistosomicidal and hepatoprotective activity of gamma-aminobutyric acid (GABA) alone or combined with praziquantel against Schistosoma mansoni infection in murine model.
    Exp Parasitol. 2022 Apr 18:108260. doi: 10.1016/j.exppara.2022.108260.
    PubMed     Abstract available
    
    
    
49. BRUSTOLIN AA, Franzoi NM, Ramos-Milare ACFH, Tanoshi CA, et al
    A standardized intraperitoneal Glucantime for experimental treatment of cutaneous leishmaniasis caused by Leishmania amazonensis in BALB/c mice.
    Exp Parasitol. 2022;236-237:108259.
    PubMed     Abstract available
    
    
    
50. ADEL MADBOULY N, Emam M, Ayman M, Ayman M, et al
    In vitro and in vivo impacts of nifedipine and diltiazem on praziquantel chemotherapy in murine Schistosoma mansoni.
    Exp Parasitol. 2022;236-237:108256.
    PubMed     Abstract available
    
    
    
51. PANDEY RK, Ojha R, Devender M, Sebastian P, et al
    Febrifugine dihydrochloride as a new oral chemotherapeutic agent against visceral leishmaniasis infection.
    Exp Parasitol. 2022;236-237:108250.
    PubMed     Abstract available
    
    
    
52. GOUVEIA ALA, Santos FAB, Alves LC, Cruz-Filho IJ, et al
    Thiazolidine derivatives: In vitro toxicity assessment against promastigote and amastigote forms of Leishmania infantum and ultrastructural study.
    Exp Parasitol. 2022;236-237:108253.
    PubMed     Abstract available
    
    
    
53. CARSON JP, Robinson MW, Ramm GA, Gobert GN, et al
    Synthetic peptides derived from the Schistosoma mansoni secretory protein Sm16 induce contrasting responses in hepatic stellate cells.
    Exp Parasitol. 2022;236-237:108255.
    PubMed     Abstract available
    
    
    March 2022
54. AVILA BRUSTOLIN A, Fernandes Herculano Ramos-Milare AC, Perles de Mello TF, Alessi Aristides SM, et al
    In vitro activity of cinnamaldehyde on Leishmania (Leishmania) amazonensis.
    Exp Parasitol. 2022;236-237:108244.
    PubMed     Abstract available
    
    
    December 2021
55. SALAZAR-VILLAMIZAR ME, Escobar P
    In vitro selection of ketoconazole-pentamidine-resistant Leishmania (Viannia) braziliensis strains.
    Exp Parasitol. 2021;233:108206.
    PubMed     Abstract available
    
    
    
56. MENDONCA DVC, Tavares GSV, Pereira IAG, Oliveira-da-Silva JA, et al
    Flau-A, a naphthoquinone derivative, is a promising therapeutic candidate against visceral leishmaniasis: A preliminary study.
    Exp Parasitol. 2021 Dec 27:108205. doi: 10.1016/j.exppara.2021.108205.
    PubMed     Abstract available
    
    
    November 2021
57. CHEN H, Li G, Zhang J, Zheng T, et al
    Sodium butyrate ameliorates Schistosoma japonicum-induced liver fibrosis by inhibiting HMGB1 expression.
    Exp Parasitol. 2021 Nov 1:108171. doi: 10.1016/j.exppara.2021.108171.
    PubMed     Abstract available
    
    
    September 2021
58. GOMES MT, Paes-Vieira L, Gomes-Vieira AL, Cosentino-Gomes D, et al
    3-Bromopyruvate: A new strategy for inhibition of glycolytic enzymes in Leishmania amazonensis.
    Exp Parasitol. 2021;229:108154.
    PubMed     Abstract available
    
    
    July 2021
59. MODABBERI F, Ghadimi SN, Shahriarirad R, Nadimi E, et al
    Stereological analysis of liver, spleen and bone of Leishmania infantum-experimentally infected hamsters.
    Exp Parasitol. 2021;228:108137.
    PubMed     Abstract available
    
    
    
60. FAHMY A, Abuelenain GL, Rasheed N, Abdou A, et al
    'de Novo' repurposing of Daflon as anti-intestinal parasitic drug in experimental giardiasis.
    Exp Parasitol. 2021;226-227:108124.
    PubMed     Abstract available
    
    
    June 2021
61. GONTIJO VS, Colombo FA, Ferreira Espuri P, Freitas PG, et al
    In vivo evaluation of anti-Leishmania activity of alkyltriazoles and alkylphosphocholines by oral route.
    Exp Parasitol. 2021 Jun 16:108123. doi: 10.1016/j.exppara.2021.108123.
    PubMed     Abstract available
    
    
    
62. KALANI M, Shams SR, Namdarnia S, Choopanizadeh M, et al
    Interleukine-22 gene variants are associated with susceptibility to visceral leishmaniasis.
    Exp Parasitol. 2021 Jun 8:108122. doi: 10.1016/j.exppara.2021.108122.
    PubMed     Abstract available
    
    
    
63. SEBAI E, Abidi A, Serairi R, Marzouki M, et al
    Essential oil of Mentha pulegium induces anthelmintic effects and reduces parasite-associated oxidative stress in rodent model.
    Exp Parasitol. 2021;225:108105.
    PubMed     Abstract available
    
    
    May 2021
64. USMAN MA, Usman FI, Abubakar MS, Salman AA, et al
    Phytol suppresses parasitemia and ameliorates anaemia and oxidative brain damage in mice infected with Plasmodium berghei.
    Exp Parasitol. 2021;224:108097.
    PubMed     Abstract available
    
    
    
65. AULA OP, McManus DP, Mason MG, Botella JR, et al
    Rapid parasite detection utilizing a DNA dipstick.
    Exp Parasitol. 2021;224:108098.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parasitic Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: